Plato BioPharma - Ownership and Business Overview

Life ScienceCompany

Plato BioPharma Ownership

Who owns Plato BioPharma?

Plato BioPharma is owned by Inotiv. It was acquired on October 4, 2021.

Plato BioPharma Business Overview

Where is Plato BioPharma headquartered?

Plato BioPharma is headquartered in Westminster, Colorado.

What sector is Plato BioPharma in?

Plato BioPharma is a life science company.

When was Plato BioPharma founded?

Plato BioPharma was founded in 2009.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.

Plato BioPharma

Plato BioPharma, Inc.

7581 W. 103rd Ave., Suite 300,
Westminster, Colorado 80021
United States,
(303) 404-7060
www.platobiopharma.com

Plato BioPharma is a biotechnology company that engages in vivo pharmacology research and drug discovery company specializing in cardiovascular, renal, pulmonary, and hepatic therapeutic areas. Plato BioPharma was founded in 2009 and is based in Westminster, Colorado.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.